Genmab Announces That The Japan Ministry Of Health, Labour And Welfare Has Approved TIVDAK For The Treatment Of Advanced Or Recurrent Cervical Cancer That Has Progressed On Or After Cancer Chemotherapy. TIVDAK Is the First And Only Antibody-Drug Conjugate